Commonwealth Fund State Performance Ranking (2007): 3
Vermont unveiled the first major component of its reform program last October. The Catamount Health Plan provides a means for uninsured Vermont residents to obtain healthcare coverage. Catamount is open to all uninsured residents, and is subsidized for individuals with incomes up to 300% of the federal poverty level (FPL).
EHR SUPPORT
Funding for the reform plan, which is expected to cost $60.6 million by 2010, has already been refigured once. Originally, nearly half of the funding was expected to come from the state's Medicaid "Global Commitment to Health" waiver. However, CMS decided federal matching funds could be used only to finance premiums for individuals with incomes up to 200% FPL. As a result, the state was forced to tap its General Fund to cover Catamount Health enrollees with incomes between 200% and 300% of the FPL.
Vermont's uninsured population is significantly lower than the national average, just more than 11% versus 18% for the United States as a whole. That's partly because the state's Medicaid program provides coverage for 19% of the state population, a much higher percentage than the national average of 13%. Even so, the fledgling reform plan has set a goal to have 96% of residents insured by 2010.
MHE Sources: Centers for Medicare & Medicaid Services; Urban Institute; Kaiser Family Foundation; U.S. Census Bureau; The Commonwealth Fund.
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Semaglutide More Effective Than Empagliflozin at Lowering Cardiovascular Risks
June 16th 2025Semaglutide appears to reduce the risk of death, heart attack and stroke in adults with type 2 diabetes more effectively than empagliflozin and dulaglutide, according to a study published in the Annals of Internal Medicine.
Read More
Teens With Hidradenitis Suppurativa Face Higher Risk of Chronic Health and Mental Health Conditions
June 16th 2025In a national study of 55 million children and teens across the U.S., there were 1,240 confirmed cases of hidradenitis suppurativa (HS). Nearly all were aged 10 or older.
Read More